Correspondence 0001104659-25-013915 from Petros Pharmaceuticals, Inc. (PTPI)
Petros Pharmaceuticals, Inc.
Date: Feb. 14, 2025 · CIK: 0001815903 · Accession: 0001104659-25-013915
AI Filing Summary & Sentiment
File numbers found in text: 333-284495
Letter
Dawson James Securities, Inc.
North Federal Highway, Suite 600
Boca Raton, Fl 33432
February 14, 2025
VIA EDGAR CORRESPONDENCE
U.S. Securities and Exchange Commission
Division of Corporation Finance
100 F Street, N.E.
Washington, D.C. 20549
Re: Petros Pharmaceuticals, Inc.
Registration Statement on Form S-1/A
File No. 333-284495
Ladies and Gentlemen:
Pursuant to Rule 461 of the General Rules and Regulations under the Securities Act of 1933, as amended (the “Act”), we, the placement agent, hereby request that the Securities and Exchange Commission (the “Commission”) take appropriate action to cause the above-referenced registration statement on Form S-1/A (the “Registration Statement”) to become effective at 4:00 p.m., Eastern Time, on Friday, February 14, 2025 or as soon thereafter as practicable.
Pursuant to Rule 460 under the Act, we wish to advise you that we have distributed as many copies of the Preliminary Prospectus dated February 14, 2025, to agents, dealers, institutions and others as appears to be reasonable to secure adequate distribution of the preliminary prospectus.
The undersigned, as placement agent, has complied and will comply with Rule 15c2-8 under the Securities Exchange Act of 1934, as amended.
If you require any additional information with respect to this letter, please contact Ali Panjwani at (212) 326-0820 of Pryor Cashman LLP.
Very truly yours,
DAWSON JAMES SECURITIES, INC.
Show Raw Text
CORRESP
1
filename1.htm
Dawson
James Securities, Inc.
101
North Federal Highway, Suite 600
Boca
Raton, Fl 33432
February 14, 2025
VIA EDGAR CORRESPONDENCE
U.S. Securities and Exchange Commission
Division of Corporation Finance
100 F Street, N.E.
Washington, D.C. 20549
Re: Petros Pharmaceuticals, Inc.
Registration Statement on Form S-1/A
File No. 333-284495
Ladies and Gentlemen:
Pursuant to Rule 461
of the General Rules and Regulations under the Securities Act of 1933, as amended (the “Act”), we, the placement agent,
hereby request that the Securities and Exchange Commission (the “Commission”) take appropriate action to cause the above-referenced
registration statement on Form S-1/A (the “Registration Statement”) to become effective at 4:00 p.m., Eastern Time, on
Friday, February 14, 2025 or as soon thereafter as practicable.
Pursuant to Rule 460
under the Act, we wish to advise you that we have distributed as many copies of the Preliminary Prospectus dated February 14, 2025,
to agents, dealers, institutions and others as appears to be reasonable to secure adequate distribution of the preliminary prospectus.
The undersigned, as placement
agent, has complied and will comply with Rule 15c2-8 under the Securities Exchange Act of 1934, as amended.
If you require any additional
information with respect to this letter, please contact Ali Panjwani at (212) 326-0820 of Pryor Cashman LLP.
Very truly yours,
DAWSON JAMES SECURITIES, INC.
By:
/s/
Robert D. Keyser, Jr.
Robert D. Keyser, Jr.
Chief Executive Officer
cc: M. Ali Panjwani, Esq.
Pryor Cashman LLP